These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes of memory B- and T-cell subsets in lupus nephritis patients. Kosalka J; Jakiela B; Musial J Folia Histochem Cytobiol; 2016; 54(1):32-41. PubMed ID: 27094637 [TBL] [Abstract][Full Text] [Related]
3. Deep Phenotyping of CD11c Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T Front Immunol; 2021; 12():635615. PubMed ID: 33777025 [TBL] [Abstract][Full Text] [Related]
4. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis. Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A Front Immunol; 2020; 11():256. PubMed ID: 32265898 [TBL] [Abstract][Full Text] [Related]
5. Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity. Faustini F; Sippl N; Stålesen R; Chemin K; Dunn N; Fogdell-Hahn A; Gunnarsson I; Malmström V Front Immunol; 2022; 13():826152. PubMed ID: 35464461 [TBL] [Abstract][Full Text] [Related]
6. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients. Wang H; Lan L; Chen J; Xiao L; Han F Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35973743 [TBL] [Abstract][Full Text] [Related]
7. Expansion and surface makers of age-associated B cells in IgG4-related disease. Zhang P; Lu H; Peng Y; Sun R; Nie Y; Li J; Peng L; Zhang W Clin Exp Rheumatol; 2024 Jan; 42(1):56-68. PubMed ID: 37470223 [TBL] [Abstract][Full Text] [Related]
8. MAIT cells altered phenotype and cytotoxicity in lupus patients are linked to renal disease severity and outcome. Litvinova E; Bounaix C; Hanouna G; Da Silva J; Noailles L; Beaudoin L; Padden M; Bellamri N; Lehuen A; Daugas E; Monteiro RC; Flament H Front Immunol; 2023; 14():1205405. PubMed ID: 37885889 [TBL] [Abstract][Full Text] [Related]
9. Increased Proportion of CD226 Nakano M; Ayano M; Kushimoto K; Kawano S; Higashioka K; Inokuchi S; Mitoma H; Kimoto Y; Akahoshi M; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H Front Immunol; 2021; 12():713225. PubMed ID: 34367178 [TBL] [Abstract][Full Text] [Related]
11. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c Wang S; Wang J; Kumar V; Karnell JL; Naiman B; Gross PS; Rahman S; Zerrouki K; Hanna R; Morehouse C; Holoweckyj N; Liu H; ; Manna Z; Goldbach-Mansky R; Hasni S; Siegel R; Sanjuan M; Streicher K; Cancro MP; Kolbeck R; Ettinger R Nat Commun; 2018 May; 9(1):1758. PubMed ID: 29717110 [TBL] [Abstract][Full Text] [Related]
12. Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients. Zhu L; Yin Z; Ju B; Zhang J; Wang Y; Lv X; Hao Z; He L Clin Rheumatol; 2018 Jan; 37(1):205-212. PubMed ID: 29067587 [TBL] [Abstract][Full Text] [Related]
13. Human T-bet governs the generation of a distinct subset of CD11c Yang R; Avery DT; Jackson KJL; Ogishi M; Benhsaien I; Du L; Ye X; Han J; Rosain J; Peel JN; Alyanakian MA; Neven B; Winter S; Puel A; Boisson B; Payne KJ; Wong M; Russell AJ; Mizoguchi Y; Okada S; Uzel G; Goodnow CC; Latour S; El Bakkouri J; Bousfiha A; Preece K; Gray PE; Keller B; Warnatz K; Boisson-Dupuis S; Abel L; Pan-Hammarström Q; Bustamante J; Ma CS; Casanova JL; Tangye SG Sci Immunol; 2022 Jul; 7(73):eabq3277. PubMed ID: 35867801 [TBL] [Abstract][Full Text] [Related]
14. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations. Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043 [TBL] [Abstract][Full Text] [Related]
16. T-bet Liu Y; Zhou S; Qian J; Wang Y; Yu X; Dai D; Dai M; Wu L; Liao Z; Xue Z; Wang J; Hou G; Ma J; Harley JB; Tang Y; Shen N Arthritis Res Ther; 2017 Oct; 19(1):225. PubMed ID: 28982388 [TBL] [Abstract][Full Text] [Related]
17. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis. Qi S; Chen Q; Xu D; Xie N; Dai Y Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035 [TBL] [Abstract][Full Text] [Related]
18. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
19. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study. Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396 [TBL] [Abstract][Full Text] [Related]
20. Investigating the Role of T-bet Sachinidis A; Trachana M; Taparkou A; Gavriilidis G; Verginis P; Psomopoulos F; Adamichou C; Boumpas D; Garyfallos A Mediterr J Rheumatol; 2023 Mar; 34(1):117-120. PubMed ID: 37223601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]